This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Axovant Sciences Ltd.
ClinicalTrials.gov Identifier:
NCT02586909
First received: October 23, 2015
Last updated: June 29, 2017
Last verified: June 2017
  Purpose
This 12-month open-label study will provide further information regarding the long-term safety and tolerability of intepirdine (RVT-101) for subjects with Alzheimer's disease who have completed the double-blind, placebo-controlled, lead-in study RVT-101-3001 (double-blind study).

Condition Intervention Phase
Alzheimer's Disease Drug: RVT-101 35 mg tablets Phase 3

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: No masking
Primary Purpose: Treatment
Official Title: A Long-Term, Open-Label Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Alzheimer's Disease

Resource links provided by NLM:


Further study details as provided by Axovant Sciences Ltd.:

Primary Outcome Measures:
  • Occurrence of adverse events (AEs) and or reported changes in physical examinations, vital signs measurements, electrocardiograms (ECGs), routine laboratory assessments [ Time Frame: Baseline to 12 months or Early Termination ]

Estimated Enrollment: 1150
Study Start Date: April 2016
Estimated Study Completion Date: June 2018
Estimated Primary Completion Date: June 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: RVT-101 35 mg tablets
once daily, oral tablets
Drug: RVT-101 35 mg tablets
once daily, oral tablets

Detailed Description:
This 12-month open-label study will provide further information regarding the long-term safety and tolerability of intepirdine (RVT-101) for subjects with Alzheimer's disease who have completed the double-blind, placebo-controlled, lead-in study RVT-101-3001. Various background therapies, including acetylcholinesterase inhibitors and memantine, will be allowed.
  Eligibility

Ages Eligible for Study:   50 Years to 86 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Completed last on-treatment visit of the lead-in study RVT-101-3001

Exclusion Criteria:

  • Any clinically relevant concomitant disease, which, in the opinion of the investigator, makes the subject unsuitable for inclusion in the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02586909

  Hide Study Locations
Locations
United States, Arizona
US112
Phoenix, Arizona, United States, 85005
US220
Tucson, Arizona, United States, 85704
United States, California
US096
Rancho Mirage, California, United States, 92270
US195
Santa Ana, California, United States, 92705
US016
Simi Valley, California, United States, 93065
US106
Temecula, California, United States, 92591
United States, Connecticut
US179
Hamden, Connecticut, United States, 06518
US171
Norwich, Connecticut, United States, 06360
United States, Florida
US088
Atlantis, Florida, United States, 33462
US007
Brooksville, Florida, United States, 34601
US002
Hallandale Beach, Florida, United States, 33009
US140
Hialeah, Florida, United States, 33012
US216
Miami, Florida, United States, 33137
US110
Miami, Florida, United States, 33165
US172
North Palm Beach, Florida, United States, 33408
US003
Orlando, Florida, United States, 32806
US256
Pensacola, Florida, United States, 32502
US037
Tampa, Florida, United States, 33613
US042
Tampa, Florida, United States, 33613
US004
The Villages, Florida, United States, 32162
United States, Georgia
US048
Atlanta, Georgia, United States, 30331
US046
Atlanta, Georgia, United States, 30342
US217
Columbus, Georgia, United States, 31909
United States, Louisiana
US111
Baton Rouge, Louisiana, United States, 70808
US095
Shreveport, Louisiana, United States, 71104
United States, Massachusetts
US116
Newton, Massachusetts, United States, 02459
US174
Quincy, Massachusetts, United States, 02169
United States, Mississippi
US144
Hattiesburg, Mississippi, United States, 39401
United States, Nevada
US094
Las Vegas, Nevada, United States, 89113
United States, New Jersey
US135
Berlin, New Jersey, United States, 08009
US197
Lawrenceville, New Jersey, United States, 08648
US057
Manchester Township, New Jersey, United States, 08759
US215
Mount Arlington, New Jersey, United States, 07856
US209
Toms River, New Jersey, United States, 08755
US036
West Long Branch, New Jersey, United States, 07764
United States, New York
US001
Albany, New York, United States, 12208
US049
Brooklyn, New York, United States, 11235
US097
New Hyde Park, New York, United States, 11040
US044
New York, New York, United States, 10022
United States, North Carolina
US150
Chapel Hill, North Carolina, United States, 27599
US185
Charlotte, North Carolina, United States, 28270
United States, Ohio
US008
Cincinnati, Ohio, United States, 45227
US113
Cleveland, Ohio, United States, 44106
US119
Shaker Heights, Ohio, United States, 44122
United States, Oregon
US134
Portland, Oregon, United States, 97210
United States, Pennsylvania
US169
Media, Pennsylvania, United States, 19063
US162
Plains, Pennsylvania, United States, 18075
US148
Willow Grove, Pennsylvania, United States, 19001
United States, Texas
US043
San Antonio, Texas, United States, 78229
United States, Utah
US143
Orem, Utah, United States, 84058
United States, Virginia
US149
Charlottesville, Virginia, United States, 22903
United States, Washington
US170
Spokane, Washington, United States, 99202
Argentina
AR101
Buenos Aires, Argentina, B1828CKR
AR084
Ciudad Autonoma de Buenos Aire, Argentina, C1012AAR
AR027
Ciudad Autonoma de Buenos Aire, Argentina, C1058AAJ
AR012
Ciudad Autonoma de Buenos Aire, Argentina, C1111AAL
AR160
Ciudad Autonoma de Buenos Aire, Argentina, C1117ABH
AR028
Ciudad Autonoma de Buenos Aire, Argentina, C1406BOA
AR040
Ciudad Autónoma de Buenos Aire, Argentina, C1405BCK
AR081
Ciudad Autónoma de Buenos Aire, Argentina, C1425AHQ
AR051
Córdoba, Argentina, X5000DCE
AR137
Córdoba, Argentina, X5000FJF
AR126
Córdoba, Argentina, X5004AOA
AR210
Mendoza, Argentina, M5501ACP
AR219
Mendoza, Argentina, M5502AHV
AR059
Santiago del Estero, Argentina, G4200DND
Australia
AU227
Caulfield, Australia, VIC 3162
AU032
Heidelberg West, Australia, VIC 3081
AU011
Hornsby, Australia, NSW 2077
AU138
West Perth, Australia, WA 6005
Bulgaria
BU125
Ruse, Bulgaria, 7003
BU131
Sofia, Bulgaria, 1431
BU073
Varna, Bulgaria, 9000
Canada, British Columbia
CA054
Kelowna, British Columbia, Canada, V1Y 1Z9
CA188
Kelowna, British Columbia, Canada, V1Y 4N7
CA186
Penticton, British Columbia, Canada, V2A 5C8
CA141
West Vancouver, British Columbia, Canada, V7T 2Z3
Canada, Ontario
CA147
Newmarket, Ontario, Canada, L3Y 5G8
CA196
North York, Ontario, Canada, M3B 2S7
Canada, Quebec
CA236
Gatineau, Quebec, Canada, J8T 8JI
Croatia
CR069
Zagreb, Croatia, 10000
CR122
Zagreb, Croatia, 10000
CR070
Zagreb, Croatia, 10090
Czechia
CZE128
Praha 10, Czechia, 100 00
CZE132
Praha 2, Czechia, 12000
CZE129
Praha 6, Czechia, 160 00
CZE207
Praha, Czechia, 100 00
CZE161
Rychnov nad Kneznou, Czechia, 516 01
France
FR231
Lille Cedex, France, 59037
FR182
Marseille Cedex 5, France, 13385
FR221
Paris Cedex, France, 75013
FR202
Villeurbanne, France, 69 100
Germany
GE206
Bad Homburg, Germany, 61348
GE091
Berlin, Germany, 10117
GE071
Berlin, Germany, 12203
GE139
Berlin, Germany, 13125
GE230
Cologne, Germany, 50937
GE252
Ellwangen, Germany, 73479
GE180
Leipzig, Germany, 04107
GE228
Mannheim, Germany, 68165
GE017
Munchen, Germany, 81675
GE157
Nürnberg, Germany, 90402
GE098
Ulm, Germany, 89081
GE251
Westerstede, Germany, 26655
Italy
IT053
Brescia, Italy, 25125
IT124
Cefalu, Italy, 90015
IT030
Pavia, Italy, 27100
IT103
Perugia, Italy, 06156
IT072
Roma, Italy, 00168
IT029
Roma, Italy, 00189
IT183
Rome, Italy, 00179
IT175
Rome, Italy, 00185
IT085
Torino, Italy, 10 126
Korea, Republic of
SK066
Busan, Korea, Republic of, 49201
SK067
Seoul, Korea, Republic of, 06351
SK190
Seoul, Korea, Republic of, 07061
Poland
PO013
Bialystok, Poland, 15-756
PO024
Bydgoszcz, Poland, 85-080
PO010
Bydgoszcz, Poland, 85-796
PO107
Katowice, Poland, 40-123
PO092
Katowice, Poland, 40-749
PO009
Poznan, Poland, 61-853
PO014
Szczecin, Poland, 70-111
PO074
Warszawa, Poland, 01-697
Serbia
SE164
Belgrade, Serbia, 11 000
SE193
Belgrade, Serbia, 11 000
SE090
Belgrade, Serbia, 11000
SE155
Kragujevac, Serbia, 34 000
SE031
Novi Kneževac, Serbia, 23330
SE165
Vršac, Serbia, 26300
Singapore
SI052
Singapore, Singapore, 119074
SI026
Singapore, Singapore, 308433
Slovakia
SL056
Banska Bystrica, Slovakia, 974 04
SL200
Dubnica nad Vahom, Slovakia, 018 41
SL078
Krompachy, Slovakia, 040 01
SL078
Krompachy, Slovakia, 05342
SL077
Svidník, Slovakia, 08901
Spain
SP249
Alicante, Spain, 03690
SP176
Barcelona, Spain, 08003
SP022
Barcelona, Spain, 08028
SP021
Barcelona, Spain, 08035
SP250
Barcelona, Spain, 08036
SP194
Donostia, Gipuzkoa, Spain, 20014
SP222
Getxo-Vizcaya, Spain, 48993
SP184
Sant Cugat del Valles, Barcelona, Spain, 08190
United Kingdom
UK063
Bath, United Kingdom, BA1 3NG
UK038
Blackpool, United Kingdom, FY2 0JH
UK233
Cambridge, United Kingdom, CB21 5EF
UK033
Carnoch, United Kingdom, WS11 0BN
UK211
Epping, United Kingdom, CM16 6TN
UK234
Guildford, United Kingdom, GU2 7YD
UK055
Leeds, United Kingdom, LS10 1DU
UK039
London, United Kingdom, W1G 9RU
UK034
Manchester, United Kingdom, M13 9NQ
UK087
Oxford, United Kingdom, OX3 9DU
UK235
Plymouth, United Kingdom, PL5 8BT
UK100
Sheffield, United Kingdom, S5 7JT
UK064
Southampton, United Kingdom, SO16 6YD
UK152
Southampton, United Kingdom, SO30 3JB
UK153
Swindon, United Kingdom, SN3 6BW
UK154
Warrington, United Kingdom, WA22 8WA
Sponsors and Collaborators
Axovant Sciences Ltd.
Investigators
Study Director: Ilise Lombardo, MD Axovant Sciences, Inc., Vice President, Clinical Research
  More Information

Responsible Party: Axovant Sciences Ltd.
ClinicalTrials.gov Identifier: NCT02586909     History of Changes
Other Study ID Numbers: RVT-101-3002
Study First Received: October 23, 2015
Last Updated: June 29, 2017

Keywords provided by Axovant Sciences Ltd.:
Alzheimer's disease
RVT-101
donepezil

Additional relevant MeSH terms:
Alzheimer Disease
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders

ClinicalTrials.gov processed this record on July 14, 2017